The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(4-(aminomethyl)piperidin-1-yl)-5-chlorophenyl)-6-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide ID: ALA3353219
PubChem CID: 58056241
Product Number: N608905, Order Now?
Max Phase: Preclinical
Molecular Formula: C19H21ClN6O2
Molecular Weight: 400.87
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cc(O)cnc23)CC1
Standard InChI: InChI=1S/C19H21ClN6O2/c20-13-1-2-17(25-5-3-12(8-21)4-6-25)16(7-13)24-19(28)15-10-23-26-11-14(27)9-22-18(15)26/h1-2,7,9-12,27H,3-6,8,21H2,(H,24,28)
Standard InChI Key: BNVZRFQNZWYPQH-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
5.4730 -10.4538 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1058 -9.3113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6390 -8.9937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1780 -7.5663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7113 -7.2519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7055 -8.3648 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1667 -9.7922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6333 -10.1067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7624 -8.0525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7662 -9.1671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2334 -8.8550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6967 -7.4283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8704 -7.1786 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.6928 -6.3138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2256 -6.6258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2234 -5.5086 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6890 -4.0818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8631 -3.8341 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 3 1 0
6 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
12 14 1 0
14 15 2 0
15 9 1 0
15 16 1 0
16 17 1 0
17 18 2 0
17 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
24 26 1 0
26 27 2 0
27 28 1 0
28 19 2 0
28 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 400.87Molecular Weight (Monoisotopic): 400.1415AlogP: 2.52#Rotatable Bonds: 4Polar Surface Area: 108.78Molecular Species: BASEHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.21CX Basic pKa: 10.22CX LogP: 1.46CX LogD: 1.28Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.62Np Likeness Score: -1.84
References 1. Chaudhary D, Robinson S, Romero DL.. (2015) Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders., 58 (1): [PMID:25479567 ] [10.1021/jm5016044 ] 2. (2016) Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators,